XEBIO Holdings CO., LTD. (8281) AI Stock Analysis

• Market Cap: ¥45.89B
• Dividend Yield: 3.31%
• Average Volume (3M): 153.55K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.28
• Revenue Growth: 0.88%
• EPS Growth: -138.66%
• Country: JP
• Employees: 2,560
• Sector: Consumer Cyclical
• Sector Strength: 84
• Industry: Specialty Retail
• EPS (TTM): -2.95
• Shares Outstanding: 47,911,022
• 10 Day Avg. Volume: 94,160
• 30 Day Avg. Volume: 153,553
• PEG Ratio: -0.93
• Price to Book (P/B): 0.46
• Price to Sales (P/S): 0.22
• P/FCF Ratio: 10.46
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: Hold
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 60 Neutral
• Price Target: ¥1,166.00 ▲(12.33% Upside)

XEBIO Holdings' stock score is primarily influenced by its strong financial position and revenue growth. However, technical indicators point to bearish momentum, and the negative P/E ratio raises concerns about profitability. The attractive dividend yield provides some support, but overall caution is advised.

Positive Factors

Strong Balance Sheet

A low Debt-to-Equity ratio indicates financial stability and flexibility, allowing XEBIO to invest in growth opportunities without excessive risk.

Revenue Growth

Consistent revenue growth reflects strong market demand and effective business strategies, supporting long-term expansion and competitiveness.

Cash Flow Improvement

Improved cash flow management enhances the company's ability to fund operations, reduce debt, and invest in future growth, strengthening financial health.

Negative Factors

Moderate Profitability

While gross margins are strong, low net margins suggest challenges in cost management or pricing power, potentially limiting profitability improvements.

Capital Expenditures Impact

High capital expenditures can constrain free cash flow, limiting the company's ability to invest in other strategic areas or return capital to shareholders.

Negative EPS Growth

Negative EPS growth indicates declining profitability, which could affect investor confidence and the company's ability to reinvest in its business.

XEBIO Holdings CO., LTD. Business Overview & Revenue Model

Company Description

XEBIO Holdings CO., LTD. (8281) is a Japan-based retail company primarily engaged in the sale of sporting goods and apparel. The company operates through various brands and stores, focusing on providing a wide range of products for sports enthusiasts, including footwear, clothing, and equipment. XEBIO also emphasizes e-commerce and online sales to enhance customer accessibility and satisfaction. Its operations span across multiple sectors within the sporting goods industry, positioning the company as a key player in the market.

How the Company Makes Money

XEBIO Holdings generates revenue primarily through the retail sales of sporting goods and apparel across its physical stores and online platforms. The company benefits from a diverse product range, which includes popular sports brands and proprietary labels, allowing for competitive pricing and customer loyalty. Significant revenue streams include in-store sales, e-commerce transactions, and seasonal promotional events. Additionally, XEBIO may engage in partnerships with sports organizations and sponsorships, further enhancing brand visibility and customer engagement, which contribute positively to its overall earnings.

XEBIO Holdings CO., LTD. Financial Statement Overview

Summary

XEBIO Holdings shows consistent revenue growth and a strong balance sheet with low leverage. However, profitability is moderate, and capital expenditures impact free cash flow ratios.

Income Statement

XEBIO Holdings has shown consistent revenue growth with a 3.37% increase in the latest year. Gross and net profit margins are healthy at 36.8% and 0.39% respectively, though the latter indicates some room for improvement in profitability. EBIT and EBITDA margins are at 2.8% and 3.64%, showing moderate operational efficiency.

Balance Sheet

The company maintains a strong financial position with a Debt-to-Equity ratio of 0.06, suggesting low leverage. A Return on Equity (ROE) of 0.8% highlights potential for increased profitability. The equity ratio stands at 59.7%, indicating substantial equity financing, which is favorable.

Cash Flow

XEBIO Holdings has demonstrated significant improvement in free cash flow, transitioning from negative to positive, signifying better cash management. The operating cash flow to net income ratio is strong at 12.42, reflecting robust cash generation relative to net income, though free cash flow to net income is lower, indicating CAPEX impacts.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	249.77B	250.60B	242.43B	239.29B	223.28B	202.44B
Gross Profit	97.23B	92.23B	92.89B	91.77B	87.05B	78.82B
EBITDA	5.62B	9.11B	9.72B	12.97B	9.25B	7.68B
Net Income	-1.53B	971.00M	2.59B	5.40B	3.84B	412.00M
Balance Sheet
Total Assets	212.61B	203.96B	209.53B	211.30B	208.31B	207.48B
Cash, Cash Equivalents and Short-Term Investments	22.07B	19.86B	24.94B	32.89B	39.89B	44.32B
Total Debt	7.26B	7.37B	9.95B	12.63B	15.18B	15.43B
Total Liabilities	91.22B	81.83B	84.72B	88.73B	89.60B	91.13B
Stockholders Equity	121.00B	121.72B	124.45B	122.36B	118.66B	116.31B
Cash Flow
Free Cash Flow	0.00	5.31B	-2.86B	1.38B	-2.78B	20.13B
Operating Cash Flow	0.00	12.06B	4.27B	7.02B	2.23B	25.37B
Investing Cash Flow	0.00	-9.60B	-8.04B	-5.48B	-5.16B	-2.02B
Financing Cash Flow	0.00	-7.53B	-4.14B	-7.91B	-2.12B	8.51B

XEBIO Holdings CO., LTD. Technical Analysis

• Technical Analysis Sentiment: Neutral
• Last Price: 1038.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8281, the sentiment is Neutral. The current price of 1038 is below the 20-day moving average (MA) of 1040.25, below the 50-day MA of 1073.14, and below the 200-day MA of 1137.00, indicating a neutral trend. The MACD of -7.48 indicates Negative momentum. The RSI at 51.97 is Neutral, neither overbought nor oversold. The STOCH value of 65.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for JP:8281.

XEBIO Holdings CO., LTD. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
9832	75 Outperform	¥127.81B	13.00	7.75%	3.63%	17.43%	248.12%
7419	74 Outperform	¥357.28B	9.10	―	1.35%	15.92%	52.76%
8282	67 Neutral	¥246.77B	23.14	―	2.72%	2.23%	57.10%
7545	65 Neutral	¥127.95B	15.50	―	1.54%	4.78%	3.50%
2678	64 Neutral	¥126.21B	17.13	10.61%	2.67%	1.69%	-57.32%
Sector *	61 Neutral	$18.38B	12.79	-2.54%	3.03%	1.52%	-15.83%
8281	60 Neutral	¥45.89B	-46.86	―	3.31%	0.88%	-138.66%

XEBIO Holdings CO., LTD. Corporate Events

XEBIO Holdings Reports Decline in Semi-Annual Financial Results

XEBIO Holdings CO., LTD. reported a decline in its consolidated financial results for the six months ended September 30, 2025, with net sales slightly decreasing by 0.7% and significant drops in operating and ordinary profits. The company revised its full-year earnings forecast, reflecting anticipated challenges in maintaining profitability, which may impact its market positioning and stakeholder confidence.

XEBIO Holdings Revises Earnings Forecast Amid Declining Sales

XEBIO Holdings Co., Ltd. announced a significant deviation between its forecasted and actual results for the second quarter of FY2026, with net sales and profits falling short due to weaker consumer sentiment and reduced customer traffic. Consequently, the company has revised its full-year earnings forecast downward, citing the ongoing uncertainty in consumer spending and its impact on future profitability.

XEBIO Finalizes Stock-Based Compensation for Directors

XEBIO Holdings Co., Ltd. has finalized the allotment of stock acquisition rights as stock-based compensation for its directors, a decision made during the Board of Directors meeting on August 19, 2025. This move involves the issuance of 18,900 common shares and is part of the company’s strategy to align director incentives with shareholder interests, potentially impacting its governance and financial strategies.